Please assess the completion status of the following clinical trial:

Trial Title: RCT of Efficacy and Safety of Sedation Compared to General Anesthesia for ERCP

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: PREVENTION
- Time Perspective: None
- Masking: TRIPLE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Patient with scheduled therapeutic ERCP~* Written informed consent for the study protocol obtained from the patient or his/her legal representative~* Anaesthetist available for the procedure~Exclusion Criteria:~* Mechanically ventilated patients before the procedure~* Baseline oxyhemoglobin saturation \< 90%~* Baseline systolic blood pressure \< 90 mm Hg~* American Society of Anaesthesiologists (ASA) physical score 5 (Table 1)~* Age \< 18 years~* Pregnancy~* Emergency procedure~* Absence of fasting ≥ 6 hours for solids and ≥ 2 hours for clear liquids~* Contraindication to any study drug~* Short, thick neck or trismus that may complicate airway rescue~* Previous documented difficult airway intubation~* Obstructive sleep apnea~* Severe swallowing disorders with documented broncho-aspiration~* Bowel obstruction~* Inclusion in the present protocol during the 30 preceding days

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Deep Sedation (Type: ACTIVE_COMPARATOR): Remifentanil 1ng/ml throughout the procedure. Propofol administration starts at an initial (estimated plasma) target concentration of 1,5 microg/ml.~Propofol administration is adjusted to level 1 or 2 on the modified observer's assessment of alertness/sedation scale. The propofol infusion will be increased stepwise by 0,5 microg/ml every 1 minute until loss of consciousness. Propofol is continued while maintaining spontaneous ventilation without assistance and systolic blood pressure ≥ 60 % of baseline systolic blood pressure.
- General Anaesthesia (Type: ACTIVE_COMPARATOR): General anesthesia will be induced with target controlled infusion (TCI) of propofol and remifentanil as in the group deep sedation.~Suxamethonium (succinylcholine) will be used to facilitate intubation. Endotracheal tube balloon pressure will be controlled during the procedure. Ventilation will be assisted using 40% oxygen in air mixture and mechanically controlled using an anaesthetic ventilator.

Based on this trial design, predict the completion outcome and termination type (if applicable).